118565082	118565082	CD	B-NP	O
|	|	NN	I-NP	O
MSH	MSH	NN	I-NP	O
|	|	NN	I-NP	O
08411049	08411049	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1863307	1863307	CD	B-NP	O
|	|	CC	I-NP	O
8/13/2006	8/13/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
SEPSIS	SEPSIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/29/2006	4/29/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/21/2006	5/21/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
TAJIMA	TAJIMA	NN	B-NP	O
,	,	,	O	O
BURT	BURT	NNP	B-NP	O
MD	MD	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Urosepsis	Urosepsis	NN	B-NP	O
.	.	.	O	O

LIST	LIST	NN	B-NP	O
OF	OF	IN	B-PP	O
PROBLEMS	PROBLEMS	NNP	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Urosepsis	Urosepsis	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hypoxic	Hypoxic	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Pneumonia	Pneumonia	NNP	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Aspiration	Aspiration	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
embolism	embolism	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Obstructive	Obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Spinal	Spinal	JJ	B-NP	O
sarcoidosis	sarcoidosis	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
66-year-old	66-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
spinal	spinal	JJ	B-NP	O
sarcoidosis	sarcoidosis	NN	I-NP	O
with	with	IN	B-PP	O
secondary	secondary	JJ	B-NP	O
paraplegia	paraplegia	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
altered	alter	VBN	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
hypoxemic	hypoxemic	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	I-NP	O
hypotension	hypotension	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
doing	do	VBG	I-VP	O
well	well	RB	B-ADVP	O
until	until	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
4/29/2006	4/29/2006	CD	B-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
breathing	breathing	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
placed	place	VBD	B-VP	O
him	him	PRP	B-NP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
CPAP	CPAP	NN	I-NP	O
machine	machine	NN	I-NP	O
that	that	IN	B-NP	O
he	he	PRP	B-NP	O
usually	usually	RB	B-ADVP	O
uses	use	VBZ	B-VP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
being	be	VBG	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
machine	machine	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
still	still	RB	I-VP	O
having	have	VBG	I-VP	O
air	air	NN	B-NP	O
hunger	hunger	NN	I-NP	O
and	and	CC	O	O
complaining	complaining	NN	B-NP	O
of	of	IN	B-PP	O
feeling	feeling	NN	B-NP	O
unwell	unwell	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
wife	wife	NN	I-NP	O
also	also	RB	B-ADVP	O
noted	note	VBD	B-VP	O
him	him	PRP	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
increasing	increase	VBG	I-VP	O
lethargy	lethargy	NN	B-NP	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
responsiveness	responsiveness	NN	B-NP	O
and	and	CC	O	O
called	call	VBD	B-VP	O
EMS	EMS	NNP	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
him	him	PRP	B-NP	O
brought	bring	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
decreased	decrease	VBN	I-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
suprapubic	suprapubic	JJ	I-NP	O
catheter	catheter	NN	I-NP	O
x2	x2	NN	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
unresponsive	unresponsive	JJ	B-ADJP	O
,	,	,	O	O
grunting	grunt	VBG	B-VP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
respiratory	respiratory	JJ	B-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
room	room	NN	I-NP	O
air	air	NN	I-NP	O
saturation	saturation	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
60	60	CD	I-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
low	low	VB	I-VP	O
70	70	CD	B-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
nonrebreather	nonrebreather	NN	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
improvement	improvement	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
saturations	saturation	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
90	90	CD	I-NP	O
's	's	POS	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
ABG	ABG	NN	I-NP	O
of	of	IN	B-PP	O
7.37	7.37	CD	B-NP	O
/	/	SYM	I-NP	O
43/77	43/77	CD	I-NP	O
on	on	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
nonrebreather	nonrebreather	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
intubated	intubate	VBN	I-VP	O
for	for	IN	B-PP	O
hypoxic	hypoxic	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
became	become	VBD	B-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
with	with	IN	B-PP	O
intubation	intubation	NN	B-NP	O
despite	despite	IN	B-PP	O
using	use	VBG	B-VP	O
etomidate	etomidate	NN	B-NP	O
with	with	IN	B-PP	O
blood	blood	NN	B-NP	O
pressures	pressure	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
60	60	CD	I-NP	O
's	's	POS	O	O
/	/	SYM	O	O
40	40	CD	B-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
initial	initial	JJ	I-NP	O
CVP	CVP	NN	I-NP	O
of	of	IN	B-PP	O
16	16	CD	B-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Levophed	Levophe	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
130	130	CD	I-NP	O
's	's	POS	B-NP	O
on	on	IN	B-PP	O
7	7	CD	B-NP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
of	of	IN	B-PP	O
Levophed	Levophed	NNP	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
received	receive	VBD	B-VP	O
1	1	CD	B-NP	O
liter	liter	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
fluid	fluid	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
head	head	NN	I-NP	O
CT	CT	NN	I-NP	O
without	without	IN	B-PP	O
contrast	contrast	NN	B-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
bleeding	bleeding	NN	I-NP	O
or	or	CC	O	O
acute	acute	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
elevated	elevate	VBN	I-VP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
CT	CT	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
without	without	IN	B-PP	O
contrast	contrast	NN	B-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
suprapubic	suprapubic	JJ	I-NP	O
catheter	catheter	NN	I-NP	O
obstruction	obstruction	NN	I-NP	O
with	with	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
hydronephrosis	hydronephrosis	NN	I-NP	O
and	and	CC	O	O
distended	distended	JJ	B-NP	O
bladder	bladder	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
2.9	2.9	CD	B-NP	O
,	,	,	O	O
elevated	elevate	VBN	B-VP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
0.9	0.9	CD	B-NP	O
.	.	.	O	O

Urology	Urology	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
to	to	TO	I-VP	O
change	change	VB	I-VP	O
the	the	DT	B-NP	O
suprapubic	suprapubic	JJ	I-NP	O
catheter	catheter	NN	I-NP	O
tube	tube	NN	I-NP	O
and	and	CC	I-NP	O
pus	pus	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
aspirated	aspirate	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
suprapubic	suprapubic	JJ	I-NP	O
catheter	catheter	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
gentamicin	gentamicin	NN	B-NP	O
,	,	,	O	O
Flagyl	Flagyl	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
stress	stress	NN	B-NP	O
dose	dose	NN	I-NP	O
steroids	steroid	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
and	and	CC	I-NP	O
urine	urine	NN	I-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Sarcoid	Sarcoid	JJ	B-NP	O
disease	disease	NN	I-NP	O
20	20	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	IN	B-ADVP	O
,	,	,	O	O
paraplegia	paraplegia	NN	B-NP	O
x18	x18	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
suprapubic	suprapubic	JJ	I-NP	O
catheter/ostomy	catheter/ostomy	NN	I-NP	O
for	for	IN	B-PP	O
12	12	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
type	type	NN	I-NP	O
II	II	CD	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
DVT	DVT	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
chronic	chronic	JJ	I-NP	O
UTI	UTI	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
CPAP	CPAP	NN	B-NP	B-protein
at	at	IN	B-PP	O
night	night	NN	B-NP	O
for	for	IN	B-PP	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

HOME	HOME	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
Regular	Regular	JJ	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
a.c.	a.c.	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
54	54	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	O	O
68	68	CD	B-NP	O
units	unit	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
,	,	,	O	O
baclofen	baclofen	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
amitriptyline	amitriptyline	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
oxybutynin	oxybutynin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
gabapentin	gabapentin	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
vitamin	vitamin	NN	B-NP	O
C	C	NN	I-NP	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
420	420	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	O	O
ranitidine	ranitidine	NN	B-NP	B-protein
150	150	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
calcium	calcium	NN	B-NP	O
950	950	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
temperature	temperature	NN	I-NP	O
was	be	VBD	B-VP	O
97.4	97.4	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
105	105	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
136/67	136/67	CD	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
O2	O2	NN	I-NP	O
saturation	saturation	NN	I-NP	O
was	be	VBD	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
AC	AC	NN	B-NP	O
700	700	CD	I-NP	O
with	with	IN	B-PP	O
PEEP	PEEP	NN	B-NP	B-protein
of	of	IN	B-PP	O
5	5	CD	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
and	and	CC	O	O
responsive	responsive	JJ	B-ADJP	O
to	to	TO	B-PP	O
simple	simple	JJ	B-NP	O
commands	command	NNS	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Sluggish	Sluggish	JJ	B-NP	O
pupils	pupil	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
anteriorly	anteriorly	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
heart	heart	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
large	large	JJ	I-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
and	and	CC	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
had	have	VBD	B-VP	O
chronic	chronic	JJ	B-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
changes	change	NNS	I-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
with	with	IN	B-PP	O
areas	area	NNS	B-NP	O
of	of	IN	B-PP	O
no	no	DT	B-NP	O
skin	skin	NN	I-NP	O
breakdown	breakdown	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
sacral	sacral	JJ	I-NP	O
decubitus	decubitus	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
with	with	IN	B-PP	O
bone	bone	NN	B-NP	O
exposed	expose	VBD	B-VP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
foul	foul	JJ	B-NP	O
smelling	smelling	NN	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
sacrum	sacrum	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
neurologically	neurologically	RB	I-VP	O
moving	move	VBG	I-VP	O
all	all	DT	B-NP	O
four	four	CD	I-NP	O
extremities	extremity	NNS	I-NP	O
and	and	CC	O	O
following	follow	VBG	B-VP	O
commands	command	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
ostomy	ostomy	NN	I-NP	O
and	and	CC	I-NP	O
suprapubic	suprapubic	JJ	I-NP	O
catheter	catheter	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
2.9	2.9	CD	B-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
Chem-7	Chem-7	NN	I-NP	B-protein
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
LFTs	LFT	NNS	I-NP	B-protein
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	B-protein
was	be	VBD	B-VP	I-protein
34.6	34.6	CD	B-NP	I-protein
,	,	,	O	O
his	his	PRP$	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
9.4	9.4	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
were	be	VBD	B-VP	O
343	343	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	B-protein
had	have	VBD	B-VP	I-protein
negative	negative	JJ	B-NP	I-protein
cardiac	cardiac	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
urine	urine	NN	I-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	O
tox	tox	NN	I-NP	O
screens	screen	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
UA	UA	NN	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	O
glucose	glucose	NN	I-NP	O
,	,	,	O	O
negative	negative	JJ	B-NP	O
ketones	ketone	NNS	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
leukocyte	leukocyte	NN	I-NP	B-protein
esterase	esterase	NN	I-NP	I-protein
,	,	,	O	O
negative	negative	JJ	B-NP	O
nitrites	nitrite	NNS	I-NP	O
,	,	,	O	O
4-10	4-10	CD	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
4	4	CD	B-NP	O
+	+	SYM	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
triple	triple	JJ	I-NP	O
phosphate	phosphate	NN	I-NP	O
crystals	crystal	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
old	old	JJ	I-NP	O
right	right	JJ	I-NP	O
bundle-branch	bundle-branch	NN	I-NP	O
block	block	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
axis	axis	NN	B-NP	O
deviation	deviation	NN	I-NP	O
,	,	,	O	O
first-degree	first-degree	JJ	B-NP	O
AV	AV	NN	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
showed	show	VBD	B-VP	O
retrocardiac	retrocardiac	JJ	B-NP	O
opacity	opacity	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
aspiration	aspiration	NN	B-NP	O
versus	versus	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
showed	show	VBD	B-VP	O
bibasilar	bibasilar	JJ	B-NP	O
airspace	airspace	NN	I-NP	O
opacities	opacity	NNS	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
right	right	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
versus	versus	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
hydronephrosis	hydronephrosis	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
decubitus	decubitus	NN	I-NP	O
ulcers	ulcer	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
large	large	JJ	B-NP	O
gastrohepatic	gastrohepatic	JJ	I-NP	O
lymph	lymph	NN	I-NP	O
nodes	node	NNS	I-NP	O
slightly	slightly	RB	B-VP	O
enlarged	enlarge	VBN	I-VP	O
and	and	CC	O	O
calcified	calcify	VBN	B-VP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
66-year-old	66-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
spinal	spinal	JJ	B-NP	O
sarcoidosis	sarcoidosis	NN	I-NP	O
and	and	CC	O	O
secondary	secondary	JJ	B-NP	O
paraplegia	paraplegia	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
altered	alter	VBN	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
hypoxemic	hypoxemic	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
hypotension	hypotension	NN	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
urosepsis	urosepsis	NN	B-NP	O
and	and	CC	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
later	later	RB	B-ADVP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
pulmonary	pulmonary	JJ	B-NP	O
embolism	embolism	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Hypoxemia	Hypoxemia	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
extubated	extubate	VBD	B-VP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
later	later	RB	B-ADVP	O
on	on	IN	B-PP	O
5/7/2006	5/7/2006	CD	B-NP	O
.	.	.	O	O

BiPAP	BiPAP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
used	use	VBN	I-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
sleep	sleep	JJ	I-NP	O
apnea	apnea	NN	I-NP	O
with	with	IN	B-PP	O
O2	O2	NN	B-NP	O
saturations	saturation	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
90	90	CD	I-NP	O
's	's	POS	B-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
with	with	IN	B-PP	O
ceftazidime	ceftazidime	NN	B-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
vancomycin	vancomycin	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
3/18/2006	3/18/2006	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
ceftazidime	ceftazidime	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
10/8/206	10/8/206	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
at	at	IN	B-PP	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	JJ	I-NP	O
10-day	10-day	JJ	I-NP	O
course	course	NN	I-NP	O
on	on	IN	B-PP	O
5/3/2006	5/3/2006	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
UTI	UTI	NN	I-NP	B-DNA
and	and	CC	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
11/8/2006	11/8/2006	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
supposed	suppose	VBN	I-VP	O
to	to	TO	I-VP	O
go	go	VB	I-VP	O
home	home	NN	B-ADVP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
desaturation	desaturation	NN	I-NP	O
to	to	TO	B-PP	O
high	high	JJ	B-NP	O
80	80	CD	I-NP	O
's	's	POS	B-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolism	embolism	NN	I-NP	O
CT	CT	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
that	that	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
nonocclusive	nonocclusive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolism	embolism	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
posterobasilar	posterobasilar	JJ	I-NP	B-DNA
segment	segment	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
with	with	IN	B-PP	O
involving	involve	VBG	B-VP	O
right	right	RB	B-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
infarct	infarct	NN	I-NP	O
suggestive	suggestive	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
PE	PE	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
resolving	resolve	VBG	I-VP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
subtherapeutic	subtherapeutic	JJ	B-ADJP	O
for	for	IN	B-PP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
at	at	IN	B-PP	O
1.7	1.7	CD	B-NP	O
to	to	TO	B-PP	O
1.9	1.9	CD	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
2.2	2.2	CD	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
PE	PE	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
subtherapeutic	subtherapeutic	JJ	I-NP	O
INR	INR	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
requirement	requirement	NN	I-NP	O
was	be	VBD	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
goal	goal	NN	I-NP	B-protein
INR	INR	NN	I-NP	I-protein
was	be	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
higher	high	JJR	I-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
2	2	CD	I-NP	O
to	to	TO	I-NP	O
3	3	CD	I-NP	O
range	range	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
goal	goal	NN	B-NP	O
previously	previously	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
given	give	VBN	I-VP	O
nebulizer	nebulizer	NN	B-NP	O
treatments	treatment	NNS	I-NP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
urine	urine	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
Proteus	Proteus	NNP	B-NP	O
,	,	,	O	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
Macrobid	Macrobid	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Klebsiella	Klebsiella	NNP	B-NP	O
,	,	,	O	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
ampicillin	ampicillin	NN	B-NP	B-protein
.	.	.	O	O

Levofloxacin	Levofloxacin	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
and	and	CC	O	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
presumed	presume	VBN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
10-day	10-day	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

Sputum	Sputum	NN	B-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
fevers	fever	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
elevated	elevate	VBN	I-NP	O
white	white	JJ	I-NP	O
counts	count	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-ADJP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
element	element	NN	I-NP	O
of	of	IN	B-PP	O
autonomic	autonomic	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
sarcoid	sarcoid	VB	I-VP	O
with	with	IN	B-PP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
hypo	hypo	NN	B-NP	O
and	and	CC	I-NP	O
hypertension	hypertension	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
.	.	.	O	O

His	His	PRP$	B-NP	O
cortisol	cortisol	NN	I-NP	O
stim	stim	NN	I-NP	O
test	test	NN	I-NP	O
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
14.5	14.5	CD	B-NP	O
before	before	IN	B-PP	O
stim	stim	NN	B-NP	O
and	and	CC	O	O
23.6	23.6	CD	B-NP	O
after	after	IN	B-PP	O
stim	stim	NN	B-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
30	30	CD	I-NP	O
's	's	POS	B-NP	O
to	to	TO	B-PP	O
160	160	CD	B-NP	O
's	's	POS	B-NP	O
with	with	IN	B-PP	O
pauses	pause	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
100	100	CD	I-NP	O
's	'	VBZ	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
with	with	IN	B-PP	O
frequent	frequent	JJ	B-NP	O
bigeminy	bigeminy	JJ	I-NP	O
and	and	CC	I-NP	O
trigeminy	trigeminy	JJ	I-NP	O
and	and	CC	I-NP	O
many	many	JJ	I-NP	O
PVCs	PVC	NNS	I-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
12.5	12.5	CD	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
metoprolol	metoprolol	NN	I-NP	O
on	on	IN	B-PP	O
7/6/2006	7/6/2006	CD	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
results	result	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
ectopy	ectopy	NN	B-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hypertensive	hypertensive	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
captopril	captopril	NN	B-NP	O
on	on	IN	B-PP	O
6/20/2006	6/20/2006	CD	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
complications	complication	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
blood	blood	NN	B-NP	O
pressures	pressure	NNS	I-NP	O
in	in	IN	B-PP	O
ideal	ideal	JJ	B-NP	O
ranges	range	NNS	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

GU	GU	NN	B-NP	O
:	:	:	O	O
Urology	Urology	NNP	B-NP	O
replaces	replace	VBZ	B-VP	O
suprapubic	suprapubic	JJ	B-NP	O
catheter	catheter	NN	I-NP	O
early	early	RB	B-ADVP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
bladder	bladder	NN	B-NP	O
irrigation	irrigation	NN	I-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
effect	effect	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Urology	Urology	NNP	B-NP	O
signed	sign	VBD	B-VP	O
off	off	RP	B-PRT	O
on	on	IN	B-PP	O
7/13/2007	7/13/2007	CD	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
NPH	NPH	NN	B-NP	O
20	20	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
through	through	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	I-NP	O
Regular	Regular	JJ	I-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
high	high	JJ	B-ADJP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
reduced	reduce	VBN	I-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	O	O
so	so	RB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
NPH	NPH	NN	I-NP	O
doses	dose	NNS	I-NP	O
for	for	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Decubitus	Decubitus	NNP	B-NP	O
ulcer	ulcer	NN	I-NP	O
:	:	:	O	O
Plastic	Plastic	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
on	on	IN	B-PP	O
4/29/2006	4/29/2006	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
look	look	VB	I-VP	O
infected	infect	VBN	I-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
debrided	debride	VBN	I-VP	O
and	and	CC	O	O
wet-to-dry	wet-to-dry	JJ	B-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
dressing	dress	VBG	B-VP	O
changes	change	NNS	B-NP	O
were	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Panafil	Panafil	NNP	B-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
dressing	dress	VBG	B-VP	O
changes	change	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
prescribed	prescribe	VBN	I-VP	O
Panafil	Panafil	NNP	B-NP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	B-ADVP	O
2.7	2.7	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
after	after	IN	B-PP	O
receiving	receive	VBG	B-VP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
came	come	VBD	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
1.2	1.2	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
likely	likely	RB	B-ADVP	O
had	have	VBD	B-VP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
postrenal	postrenal	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
around	around	IN	B-NP	O
1	1	CD	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
DVT	DVT	NN	B-NP	B-protein
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
so	so	IN	O	O
the	the	DT	B-NP	O
plan	plan	NN	I-NP	O
was	be	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
half	half	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
dose	dose	NN	I-NP	O
while	while	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
half	half	NN	B-NP	O
of	of	IN	B-PP	O
dose	dose	NN	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
INRs	INR	NNS	I-NP	B-protein
came	come	VBD	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
nadir	nadir	NN	I-NP	O
of	of	IN	B-PP	O
1.7	1.7	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
subtherapeutic	subtherapeutic	JJ	B-ADJP	O
for	for	IN	B-PP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
PE	PE	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
1.8	1.8	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
day	day	NN	I-NP	O
after	after	IN	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
2	2	CD	B-NP	O
and	and	CC	O	O
then	then	RB	O	O
came	come	VBD	B-VP	O
up	up	RB	B-ADVP	O
to	to	TO	B-PP	O
2.2	2.2	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
at	at	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
Coumadin	Coumadin	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
maintenance	maintenance	NN	B-NP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
until	until	IN	B-SBAR	O
cleared	clear	VBN	B-VP	O
to	to	TO	B-VP	O
eat	eat	VB	I-VP	O
by	by	IN	B-PP	O
Speech	Speech	NNP	B-NP	O
and	and	CC	I-NP	O
Swallow	Swallow	NNP	I-NP	O
.	.	.	O	O

Speech	Speech	NN	B-NP	O
and	and	CC	I-NP	O
Swallow	Swallow	NN	I-NP	O
estimates	estimate	NNS	I-NP	O
having	have	VBG	B-VP	O
baseline	baseline	NN	B-NP	O
aspiration	aspiration	NN	I-NP	O
risk	risk	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	B-PP	O
cough	cough	NN	B-NP	O
and	and	CC	I-NP	O
aspirate	aspirate	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
recently	recently	RB	B-ADVP	O
worked	work	VBD	B-VP	O
up	up	RP	B-PRT	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
A	A	NNP	I-NP	O
County	County	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
admission	admission	NN	I-NP	O
for	for	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
thickened	thicken	VBN	I-VP	O
puree	puree	JJ	B-NP	O
diets	diet	NNS	I-NP	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
even	even	RB	B-NP	O
this	this	DT	I-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
aspirate	aspirate	VB	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
risks	risk	NNS	I-NP	O
and	and	CC	I-NP	O
benefits	benefit	NNS	I-NP	O
of	of	IN	B-PP	O
eating	eating	NN	B-NP	O
were	be	VBD	B-VP	O
explained	explain	VBN	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
and	and	CC	O	O
him	him	PRP	B-NP	O
and	and	CC	I-NP	O
he	he	PRP	I-NP	O
decided	decide	VBD	B-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
eat	eat	VB	I-VP	O
as	as	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
ideal	ideal	JJ	I-NP	O
option	option	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	B-protein
continued	continue	VBD	B-VP	I-protein
gabapentin	gabapentin	NN	B-NP	I-protein
,	,	,	O	O
oxybutynin	oxybutynin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
amitriptyline	amitriptyline	NN	B-NP	O
as	as	IN	B-PP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Nexium	Nexium	NN	B-NP	O
and	and	CC	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Code	Code	NN	B-NP	O
status	status	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
discussed	discuss	VBN	I-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
AT	AT	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
current	current	JJ	I-NP	O
temperature	temperature	NN	I-NP	O
was	be	VBD	B-VP	O
98	98	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
91	91	CD	B-NP	O
to	to	TO	B-PP	O
114	114	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
100-114/54	100-114/54	CD	I-NP	O
-70	-70	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
saturating	saturate	VBG	B-VP	O
97-100	97-100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
1-2	1-2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
responsive	responsive	JJ	B-ADJP	O
,	,	,	O	O
alert	alert	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
appropriate	appropriate	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
heart	heart	NN	I-NP	O
had	have	VBD	B-VP	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
soft	soft	JJ	B-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
had	have	VBD	B-VP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
distended	distended	JJ	B-ADJP	O
,	,	,	I-ADJP	O
soft	soft	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
suprapubic	suprapubic	JJ	I-NP	O
catheter	catheter	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
an	an	DT	B-NP	O
ostomy	ostomy	NN	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
clean	clean	JJ	B-ADJP	O
,	,	,	I-ADJP	O
dry	dry	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
peripheral	peripheral	JJ	I-NP	O
edema	edema	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
skin	skin	NN	I-NP	O
breakdown	breakdown	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
VALUES	VALUES	NNS	I-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
labs	lab	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	B-protein
was	be	VBD	B-VP	I-protein
27.2	27.2	CD	B-NP	I-protein
,	,	,	O	O
down	down	RB	B-ADVP	O
from	from	IN	B-PP	O
29	29	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
closed	close	VBN	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
34	34	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
2.1	2.1	CD	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
discharge	discharge	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Amitriptyline	Amitriptyline	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
vitamin	vitamin	NN	B-NP	O
C	C	NN	I-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
baclofen	baclofen	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Caltrate	Caltrate	NNP	B-NP	O
600	600	CD	I-NP	O
Plus	Plus	NN	I-NP	O
D	D	NN	I-NP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
ferrous	ferrous	JJ	B-NP	O
sulfate	sulfate	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
gabapentin	gabapentin	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
human	human	JJ	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
54	54	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
68	68	CD	B-NP	O
units	unit	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
Regular	Regular	JJ	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
to	to	TO	B-VP	O
end	end	VB	I-VP	O
on	on	IN	B-PP	O
11/23/2006	11/23/2006	CD	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
oxide	oxide	NN	I-NP	O
420	420	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
metoprolol	metoprolol	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
oxybutynin	oxybutynin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Panafil	Panafil	NN	B-NP	O
ointment	ointment	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
ranitidine	ranitidine	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

FOLLOW	FOLLOW	JJ	B-NP	O
UP	UP	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Dunstan	Dunstan	NNP	I-NP	O
The	The	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Carros	Carros	NNP	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Coumadin	Coumadin	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
tomorrow	tomorrow	NN	B-NP	O
or	or	CC	O	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

ISSUES	ISSUES	NNP	B-NP	O
FOR	FOR	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
:	:	:	O	O
Include	Include	NNP	B-NP	O
following	follow	VBG	B-PP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
aspiration	aspiration	NN	I-NP	O
risk	risk	NN	I-NP	O
and	and	CC	O	O
continuing	continue	VBG	B-VP	O
to	to	TO	I-VP	O
discourage	discourage	VB	I-VP	O
thin	thin	JJ	B-NP	O
liquids	liquid	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
encourage	encourage	VB	B-VP	O
him	him	PRP	B-NP	O
sitting	sit	VBG	B-VP	O
upright	upright	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
eating	eat	VBG	B-VP	O
and	and	CC	O	O
being	be	VBG	B-VP	O
observed	observe	VBN	I-VP	O
and	and	CC	O	O
stopping	stop	VBG	B-VP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
coughs	cough	VBZ	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
continuous	continuous	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
monitoring	monitor	VBG	B-VP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
new	new	JJ	I-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
assessment	assessment	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	B-cell_type
frequent	frequent	JJ	I-NP	I-cell_type
PVCs	PVC	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
his	his	PRP$	B-NP	O
diabetes	diabete	NNS	I-NP	O
and	and	CC	O	O
continue	continue	VBP	B-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
being	be	VBG	B-VP	O
2	2	CD	B-NP	O
to	to	TO	B-PP	O
3	3	CD	B-NP	O
with	with	IN	B-PP	O
ideal	ideal	JJ	B-NP	O
goal	goal	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
higher	high	JJR	I-NP	O
end	end	NN	I-NP	O
8	8	CD	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
3-2223778	3-2223778	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
PITTARI	PITTARI	NNP	B-NP	O
,	,	,	O	O
NIGEL	NIGEL	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SIFFERT	SIFFERT	NNP	B-NP	O
,	,	,	O	O
TROY	TROY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
8789609	8789609	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
5/26/06	5/26/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/26/06	5/26/06	CD	B-NP	O

